Release Date: 27/07/21 14:45 Summary: Quarterly Activities/Appendix 4C Cash Flow Report Price Sensitive: Yes Download Document 1.16MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status